Pharma Components ApS: Financial statements 2022
CVR: 39103079
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Pharma Components ApS (CVR 39103079) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 68,538 and a net result of DKK 57,077 compared with DKK -22,820 the year before. Equity in the 2022 report amounted to DKK 49,378. The solvency ratio was 38.8%.
- Gross Profit
- DKK 68,538
- Profit/Loss
- DKK 57,077
- Equity
- DKK 49,378
- Total Assets
- DKK 127,287
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 69 t. | 57 t. | 49 t. | 0 |
| 2021 | - | -22 t. | -23 t. | -8 t. | 0 |
| 2020 | - | -17 t. | -15 t. | 15 t. | 0 |
| 2019 | - | 45 t. | 35 t. | 31 t. | - |
Keep an eye on Pharma Components ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Pharma Components ApS has published its annual report for 2021. Gross profit came to DKK -21,907, and the net result was DKK -22,820.
About Pharma Components ApS
Pharma Components ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2017. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named Pharma Components IVS. The management consists of Anders Fossing Riel. The company is owned by A.Rocket Holding ApS. In 2025, the company reported a gross profit of DKK -35,183 and a net result of DKK -115,173 compared with DKK 142,048 the year before. Equity in the 2025 report amounted to DKK 272,393.